188 related articles for article (PubMed ID: 23347286)
21. Platelet apoptosis and activation in platelet concentrates stored for up to 12 days in plasma or additive solution.
Cookson P; Sutherland J; Turner C; Bashir S; Wiltshire M; Hancock V; Smith K; Cardigan R
Transfus Med; 2010 Dec; 20(6):392-402. PubMed ID: 20738829
[TBL] [Abstract][Full Text] [Related]
22. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days.
Shanwell A; Diedrich B; Falker C; Jansson B; Sandgren P; Sundkvist L; Svensson L; Vesterinen M; Gulliksson H
Transfusion; 2006 Jun; 46(6):973-9. PubMed ID: 16734814
[TBL] [Abstract][Full Text] [Related]
23. In vitro analysis of volume-reduced washed platelet concentrates stored in bicarbonated Ringer's solution containing less than 5% residual plasma.
Oikawa S; Minegishi M; Endo K; Kawashima W; Suzuki K; Shimizu H
Vox Sang; 2016 Jul; 111(1):16-21. PubMed ID: 26918327
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system.
Vetlesen A; Mirlashari MR; Ezligini F; Kjeldsen-Kragh J
Transfusion; 2007 Jan; 47(1):126-32. PubMed ID: 17207241
[TBL] [Abstract][Full Text] [Related]
25. In vitro quality of single-donor platelets treated with riboflavin and ultraviolet light and stored in platelet storage medium for up to 8 days.
Cookson P; Thomas S; Marschner S; Goodrich R; Cardigan R
Transfusion; 2012 May; 52(5):983-94. PubMed ID: 22014032
[TBL] [Abstract][Full Text] [Related]
26. The effect of pathogen reduction technology (Mirasol) on platelet quality when treated in additive solution with low plasma carryover.
Johnson L; Winter KM; Reid S; Hartkopf-Theis T; Marschner S; Goodrich RP; Marks DC
Vox Sang; 2011 Oct; 101(3):208-14. PubMed ID: 21492184
[TBL] [Abstract][Full Text] [Related]
27. In vitro evaluation of prestorage pools consisting of mixed A and O platelet concentrates.
Sweeney J; Kouttab N; Holme S; Cheves T; Nelson E
Transfusion; 2007 Jul; 47(7):1154-61. PubMed ID: 17581149
[TBL] [Abstract][Full Text] [Related]
28. In vitro variables of apheresis platelets are stably maintained for 7 days with 5% residual plasma in a glucose and bicarbonate salt solution, PAS-5.
Radwanski K; Wagner SJ; Skripchenko A; Min K
Transfusion; 2012 Jan; 52(1):188-94. PubMed ID: 21790624
[TBL] [Abstract][Full Text] [Related]
29. In vitro quality of platelets during prolonged storage after washing with three platelet additive solutions.
Tynngård N; Trinks M; Berlin G
Vox Sang; 2012 Jan; 102(1):32-9. PubMed ID: 21534983
[TBL] [Abstract][Full Text] [Related]
30. Effects of immediate or delayed addition of platelet additive solution on the in vitro quality of apheresis platelets.
Ringwald J; Tully S; Geier C; Hauck B; Weiss D; Callaert M; Eckstein R
Transfusion; 2012 Jun; 52(6):1237-44. PubMed ID: 22070790
[TBL] [Abstract][Full Text] [Related]
31. Platelet ADP response deteriorates in synthetic storage media.
Keuren JF; Cauwenberghs S; Heeremans J; de Kort W; Heemskerk JW; Curvers J
Transfusion; 2006 Feb; 46(2):204-12. PubMed ID: 16441596
[TBL] [Abstract][Full Text] [Related]
32. Impact of the platelet washing process on in vitro platelet properties, and the levels of soluble CD40 ligand and platelet-derived microparticles in the storage media.
Oikawa S; Minegishi M; Endo K; Kawashima W; Kosunago S; Oyama M; Suzuki K; Shimizu H
Transfusion; 2019 Mar; 59(3):1080-1089. PubMed ID: 30588642
[TBL] [Abstract][Full Text] [Related]
33. In vitro properties of platelets stored in three different additive solutions.
Tynngård N; Trinks M; Berlin G
Transfusion; 2012 May; 52(5):1003-9. PubMed ID: 22043825
[TBL] [Abstract][Full Text] [Related]
34. Extended storage of platelets in SSP platelet additive solution.
Hornsey VS; McColl K; Drummond O; McMillan L; Morrison A; Morrison L; MacGregor IR; Prowse CV
Vox Sang; 2006 Jul; 91(1):41-6. PubMed ID: 16756600
[TBL] [Abstract][Full Text] [Related]
35. Storage of platelet-rich plasma-derived platelet concentrate pools in plasma and additive solution.
Sweeney J; Kouttab N; Holme S; Kurtis J; Cheves T; Nelson E
Transfusion; 2006 May; 46(5):835-40. PubMed ID: 16686852
[TBL] [Abstract][Full Text] [Related]
36. Measurement of phosphatidylserine exposure during storage of platelet concentrates using the novel probe lactadherin: a comparison study with annexin V.
Albanyan AM; Murphy MF; Rasmussen JT; Heegaard CW; Harrison P
Transfusion; 2009 Jan; 49(1):99-107. PubMed ID: 18954406
[TBL] [Abstract][Full Text] [Related]
37. Platelets stored in a new-generation container differences between plasma and platelet additive solution II.
de Wildt-Eggen J; Schrijver JG; Smid WM; Joie M; Bollinne V; Bins M
Vox Sang; 1998; 75(3):218-23. PubMed ID: 9852410
[TBL] [Abstract][Full Text] [Related]
38. Ultrastructural changes and activation differences in platelet concentrates stored in plasma and additive solution.
Wagner T; Vetter A; Dimovic N; Guber SE; Helmberg W; Kröll W; Lanzer G; Mayr WR; Neumüller J
Transfusion; 2002 Jun; 42(6):719-27. PubMed ID: 12147024
[TBL] [Abstract][Full Text] [Related]
39. Cryopreservation of buffy-coat-derived platelet concentrates in dimethyl sulfoxide and platelet additive solution.
Johnson LN; Winter KM; Reid S; Hartkopf-Theis T; Marks DC
Cryobiology; 2011 Apr; 62(2):100-6. PubMed ID: 21241687
[TBL] [Abstract][Full Text] [Related]
40. Hyperconcentrated platelets stored in additive solution: aspects on productivity and in vitro quality.
Ringwald J; Walz S; Zimmermann R; Zingsem J; Strasser E; Weisbach V; Eckstein R
Vox Sang; 2005 Jul; 89(1):11-8. PubMed ID: 15938735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
